Cure Rare Disease

📍 Boston, United States🗓 Founded 2017👥 18 employees💰 Last funded Apr 2024
Biotechnology🌐 cureraredisease.org
Website LinkedIn
Cure Rare Disease is a nonprofit biotechnology company whose mission is to enable and finance the development of life-saving genetic medicines for rare and ultra-rare patient populations previously deemed too rare to treat. To realize this, our unique ecosystem facilitates collaboration between world-renowned researchers and clinicians, policy experts and our generous donors. Together, we are fundamentally changing the rare and ultra-rare disease experience and burden for millions of people around the world with our discoveries and methods—while bringing hope to patients waiting for a cure.
7
Total investors
6
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Early stage· 6
?
Board Member
early stage
Oct 2019
?
Board Member
early stage
Jun 2019
?
Board Member
early stage
Apr 2019
?
Board Member
early stage
Apr 2019
?
Board member
early stage
Dec 2017
?
Board Member
early stage
Aug 2017
Late stage· 1
Klaus Veitinger
Klaus Veitinger
Venture Partner at OrbiMed Advisors | Experienced Biopharmaceutical Executive and Investor | Brain Cancer Advocate
Board Member
late stage
5 investments
Apr 2024
Investor geography1 country
United States
1
Investor activity2017–2024 · investors recorded per year
201722019420241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cure Rare Disease?
Cure Rare Disease has 7 investors on record on gritt.io, including 6 early-stage backers and 1 late-stage investors.
When did Cure Rare Disease last raise funding?
The most recent investment in Cure Rare Disease recorded on gritt.io was in April 2024.
When was Cure Rare Disease founded?
Cure Rare Disease was founded in 2017.
What industry is Cure Rare Disease in?
Cure Rare Disease operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cure Rare Disease based?
Cure Rare Disease is headquartered in Boston, United States.